Vitiligo after Diphencyprone for Alopecia Areata
The topical immunotherapy is used to treat alopecia areata and recalcitrant warts since the 1970s. Diphencyprone is a contact sensitizer used to treat dermatological conditions resulting from as altered immunological state, such as extensive alopecia areata, being partially effective and safe. Side...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Dermatology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2010/171265 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832554892396331008 |
|---|---|
| author | Mario Cezar Pires João Mauricio Martins F. Montealegre Flávia Romero Gatti |
| author_facet | Mario Cezar Pires João Mauricio Martins F. Montealegre Flávia Romero Gatti |
| author_sort | Mario Cezar Pires |
| collection | DOAJ |
| description | The topical immunotherapy is used to treat alopecia areata and recalcitrant warts since the 1970s. Diphencyprone is a contact sensitizer used to treat dermatological conditions resulting from as altered immunological state, such as extensive alopecia areata, being partially effective and safe. Side effects include local eczema with blistering, regional lymphadenopathy and contact urticaria. Rare adverse effects include an erythema multiforme-like reaction, hyperpigmenttion, hypopigmentation, and vitiligo. We report a 30-year-old, Brazilian male who developed vitiligo lesions following DPCP therapy for alopecia areata. |
| format | Article |
| id | doaj-art-1d81a0977ba64e56a53e5b3eef7fbbe9 |
| institution | Kabale University |
| issn | 1687-6105 1687-6113 |
| language | English |
| publishDate | 2010-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Dermatology Research and Practice |
| spelling | doaj-art-1d81a0977ba64e56a53e5b3eef7fbbe92025-02-03T05:50:07ZengWileyDermatology Research and Practice1687-61051687-61132010-01-01201010.1155/2010/171265171265Vitiligo after Diphencyprone for Alopecia AreataMario Cezar Pires0João Mauricio Martins1F. Montealegre2Flávia Romero Gatti3Dermatology Department, Complexo Hospitalar Padre Bento de Guarulhos, Saõ Paulo, BrazilDermatology Department, Complexo Hospitalar Padre Bento de Guarulhos, Saõ Paulo, BrazilPonce School of Medicine, Puerto Rico, USADermatology Department, Complexo Hospitalar Padre Bento de Guarulhos, Saõ Paulo, BrazilThe topical immunotherapy is used to treat alopecia areata and recalcitrant warts since the 1970s. Diphencyprone is a contact sensitizer used to treat dermatological conditions resulting from as altered immunological state, such as extensive alopecia areata, being partially effective and safe. Side effects include local eczema with blistering, regional lymphadenopathy and contact urticaria. Rare adverse effects include an erythema multiforme-like reaction, hyperpigmenttion, hypopigmentation, and vitiligo. We report a 30-year-old, Brazilian male who developed vitiligo lesions following DPCP therapy for alopecia areata.http://dx.doi.org/10.1155/2010/171265 |
| spellingShingle | Mario Cezar Pires João Mauricio Martins F. Montealegre Flávia Romero Gatti Vitiligo after Diphencyprone for Alopecia Areata Dermatology Research and Practice |
| title | Vitiligo after Diphencyprone for Alopecia Areata |
| title_full | Vitiligo after Diphencyprone for Alopecia Areata |
| title_fullStr | Vitiligo after Diphencyprone for Alopecia Areata |
| title_full_unstemmed | Vitiligo after Diphencyprone for Alopecia Areata |
| title_short | Vitiligo after Diphencyprone for Alopecia Areata |
| title_sort | vitiligo after diphencyprone for alopecia areata |
| url | http://dx.doi.org/10.1155/2010/171265 |
| work_keys_str_mv | AT mariocezarpires vitiligoafterdiphencyproneforalopeciaareata AT joaomauriciomartins vitiligoafterdiphencyproneforalopeciaareata AT fmontealegre vitiligoafterdiphencyproneforalopeciaareata AT flaviaromerogatti vitiligoafterdiphencyproneforalopeciaareata |